• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIABETES CARE, INC. ACCU-CHEK ® RAPIDLINK INFUSION SET; SUBCUTANEOUS INFUSION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIABETES CARE, INC. ACCU-CHEK ® RAPIDLINK INFUSION SET; SUBCUTANEOUS INFUSION SET Back to Search Results
Catalog Number 04545192001
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Reaction, Injection Site (2442)
Event Date 10/26/2018
Event Type  Injury  
Manufacturer Narrative
The event occurred outside of the united states while this product is not sold in the united states, it is like or similar to a product marketed in the united states.
 
Event Description
The caller reported that the patient had an allergic reaction to the infusion set.It was reported that the patient had an abscess in various locations on the abdominal area.On (b)(6) 2018 the patient inserted a new radid-d link cannula; by friday, (b)(6) 2018, the area was red and presented pain.The patient went to the doctor.The doctor presumed that it was deep-seated encapsulated pus, caused by a delayed reaction to the steel rapid-d link cannula.It was determined that the patient would need surgery.The first surgery took place on (b)(6) 2018 with a superficial incision to remove pus.However, through this process no pus was extracted.On (b)(6) 2018 the patient underwent a 2nd surgery under general anesthesia.The pus was removed by placing a tube inside the wound.It was reported that there would be a 3rd surgery to take place on (b)(6) 2018.The patient would be under general anesthesia for removal of two further small abscesses (one newly formed on (b)(6) 2018, another older one).Both abscesses also occurred in places where the infusion set had previously been placed.At the time of the report the patient was still hospitalized, it is unknown when they will be discharged.The infusion set was requested to be returned for product evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCU-CHEK ® RAPIDLINK INFUSION SET
Type of Device
SUBCUTANEOUS INFUSION SET
Manufacturer (Section D)
ROCHE DIABETES CARE, INC.
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
FRESENIUS KABI DEUTSCHLAND GMBH
robert-koch-strasse 5
na
bad hersfeld D-362 51
GM   D-36251
Manufacturer Contact
greg smith
9115 hague road
na
indianapolis, IN 46250-0457
3175212484
MDR Report Key8059780
MDR Text Key126906039
Report Number3011393376-2018-04689
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Reporter Country CodeGM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 01/23/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/12/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date10/15/2022
Device Catalogue Number04545192001
Device Lot Number32463417
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received01/11/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age16 YR
-
-